| 4BASEBIO PLC EO 1 |
| Großbritannien |
| Gesundheit |
| GB00BMCLYF79 / A3CWA4 |
| 88Q (Frankfurt) |
| FRA:88Q, ETR:88Q, 88Q:GR |
| - |
| https://4basebio.com/ |
|
4basebio PLC is a biotechnology company with a focus on the development and commercialization of technologies for gene therapy and DNA manufacturing. The company's primary purpose is to advance the delivery of gene therapies by addressing key challen..
>Volltext.. |
| 86.92 Mio. EUR |
| 85.43 Mio. EUR |
| 1.97 Mio. EUR |
| -18.09 Mio. EUR |
| -19.63 Mio. EUR |
| -1.27 EUR |
| 19.16 Mio. EUR |
| 20.67 Mio. EUR |
| - |
| 6.3 |
| 72.22% |
| -30.1% |
| - |
| - |
| - |
| - |
| 4BASEBIO, 4 BASEBIO |
| 23.05.26 |
|